HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroepidemiology of HCV-HIV coinfection in Tunisia.

AbstractAIM:
To determine the prevalence of antibodies to hepatitis C virus (HCV) in a cohort of patients infected with human immunodeficiency virus 1 (HIV-1) and to compare risk factors.
METHODS:
Multicenter retrospective study from infectious diseases department in Tunisia. We examined sera from HIV patients followed in these centers. Diagnosis of HCV infection was based on third generation enzyme-linked immunosorbent assay (ELISA) test.
RESULTS:
362 HIV-1 patients were included in the study. The mean age was 35,5 years. 272 patients (75.13%) were male. Sexual transmission of HIV was the main risk factor (56.3%). 144 patients (39.7%) had antibodies against HCV, mainly in patients with history of intravenous drug abuse (78.4%). Quantitative evaluation of hepatitis C virus RNA was done only in 3 patients.
CONCLUSION:
HCV-HIV coinfection in tunisian patients occurs frequently, due to the same ways of transmission. More studies are needed to focus on sexual transmission of hepatitis C virus in order to prevent such infections rather than interferon-based therapies.
AuthorsBadreddine Kilani, Lamia Ammari, Chekib Marrakchi, Amel Letaief, Mohamed Chakroun, Mounir Ben Jemaa, Hanene Tiouiri Ben Aïssa, Fakher Kanoun, Taoufik Ben Chaabène
JournalLa Tunisie medicale (Tunis Med) Vol. 85 Issue 2 Pg. 121-3 (Feb 2007) ISSN: 0041-4131 [Print] Tunisia
PMID17665657 (Publication Type: Journal Article, Multicenter Study)
Chemical References
  • Antibodies, Viral
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral (blood)
  • Female
  • HIV Infections (epidemiology, transmission)
  • Hepacivirus (immunology)
  • Hepatitis C (epidemiology, transmission)
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Tunisia (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: